AUG 13, 2026 · PHASE 2 TRIAL
T Cell Receptor Immunotherapy for Patients With Metastatic Non-Small Cell Lung Cancer
ClinicalTrials.gov
This is a Phase 2 trial registration with no posted results; the study is actively recruiting and has not yet reported efficacy or safety outcomes.
Reported
Planned enrollment85
Primary outcome measureResponse rate at 6 and 12 weeks after cell…
Trial phasePhase 2